Determinants of the Response to BTK Degraders (BTKd) in Chronic Lymphocytic Leukemia

计划入组 60 人 · 首次发布于 2025 年 8 月 1 日

Mutation of the BTK Gene and Genotype-phenotype Correlation of Chinese Patients With X-Linked Agammaglobulinemia

计划入组 100 人 · 首次发布于 2014 年 9 月 9 日

Global Trial in APG2575 for Patients With CLL/SLL

计划入组 400 人 · 首次发布于 2023 年 10 月 27 日

BTK-001

BTK inhibitors (MannKind)

BTK-Max

NTK ENTERPRISES, INC.

United States

BTG International Inc.

United States

BTG INTERNATIONAL INC

United States

AngioDynamics Launches AMBITION BTK Trial to Evaluate Auryon Laser System for Critical Limb Ischemia

AngioDynamics Launches AMBITION BTK Trial for Critical Limb Ischemia Treatment Using Auryon Laser Technology

Radiopharmaceutical Antibody-Drug Conjugates (rADCs) Emerge as Promising Cancer Therapies